ADAR and cancer: Sustained activation of dsRNA sensor pathway by ADAR1 deletion also reduces cancer cell viability, as shown by the application of anti-cancer epigenetic inhibitors capable of inducing the transcription of repetitive sequences that form dsRNAs (Fig. 5G) (Chen et al., 2021; Chung et al., 2018; Liu et al., 2019).